Year: 2014
Type: article
Abstract: New drugs that could revolutionize the treatment of drug-sensitive and drug-resistant TB are imminently available. Moreover recent research of pharmacokinetic-pharmacodynamic relationships in adults suggests that the doses of some currently used drugs should be changed. It is imperative that children access these improvements to TB treatment without delay.
Author: H. McIlleron
Institution: University of Cape Town
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,900
OpenAlex ID: W1984720982
